—
C+
C+ The full Closelooknet — membership. Open the C+ overview

CG Oncology, Inc. Common stock (CGON) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Uptrend stack intact — Trades +6.5% vs the 50-day and +9.4% vs the 200-day average, 10.3% below the 52-week high and +102.9% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
  • Trend: CG Oncology, Inc. Common stock trades 6.5% above its 50-day and 9.4% above its 200-day moving average. (as of 2026-11-10)

CG Oncology develops cretostimogene, an experimental virus-based immunotherapy that trains the immune system to attack bladder tumours after standard BCG treatment fails. The company runs several late-stage trials testing the therapy alone in different bladder-cancer stages, from high-risk disease to intermediate-risk cases after surgery.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the CGON overview. Research diary readings, not advice.

Uptrend stack intact

Trades +6.5% vs the 50-day and +9.4% vs the 200-day average, 10.3% below the 52-week high and +102.9% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the CGON chart & overview · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on CGON?

Uptrend stack intact — Trades +6.5% vs the 50-day and +9.4% vs the 200-day average, 10.3% below the 52-week high and +102.9% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is CGON above its 50-day and 200-day moving averages?

As of 2026-11-10, CG Oncology, Inc. Common stock trades +6.5% above its 50-day and +9.4% above its 200-day average, with the 20-day +12.6% away.

How far is CGON from its 52-week high?

10.3% below the 52-week high and 102.9% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.